Skip to main content

Table 3 5-year overall, disease free, locoregional recurrence free- and distant recurrence free survival rates depending on the sequencing of chemo- and radiotherapy

From: Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis

    5-year OS rate   5-year DFS rate   5-year LRS rate   5-year DRS rate  
    % p* % p* % p* % p*
All patients n (%) 212 (100 %) 53   46   75.7   56.4  
Sequencing of chemo- and radiotherapy n (%) SEQ 86 (40.6) 53.2 0.04 56 0.03 88 0.09 60.2 0.1
  SW 70 (33) 38.1   32   57.9   49.8  
  SIM 56 (26.4) 64.2   50   77.4   59.8  
  1. (* p-values of log-rank tests comparing survival times between different sequences)